Save Billions or Stick With Humira? Drug Brokers Steer Americans to the Costly Choice

Thousands of patients with autoimmune diseases who rely on Humira, with a list price of $6,600 a month, could get financial relief from new low-cost rivals. So far, the pharmacy benefit managers that control drug prices in America have not delivered on those savings.
http://dlvr.it/SwK2Bm

Comments

Popular posts from this blog

Bustos on Bloomberg TV: In Last Two Weeks, “Price of Gas Has Gone Down Forty Cents”